Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time
Kodiak Sciences (Nasdaq: KOD) is hosting its Investor R&D Day today in New York from 10:30 am to 12:30 pm ET. The event can be accessed virtually and will feature presentations from Kodiak's leadership team and leading retina specialist key opinion leaders. The agenda includes discussions on the science of durability, enhanced formulation, clinical program overview, and the Kodiak opportunity.
Speakers include David Brown, MD, Clinical Professor of Ophthalmology at Baylor College of Medicine, and Charles Wykoff, MD, PhD, Clinical Professor of Ophthalmology at Weill Cornell Medical College. The event will also preview Kodiak's ABCD Platform and conclude with a summary and audience Q&A session.
A live webcast, replay, and presentation slides will be available on Kodiak's Investors & Media website. This event provides an opportunity for investors to gain insights into Kodiak's research and development efforts in the field of ophthalmology.
Kodiak Sciences (Nasdaq: KOD) ospita oggi il suo Investor R&D Day a New York dalle 10:30 alle 12:30 ET. L'evento sarà accessibile virtualmente e includerà presentazioni da parte del team dirigente di Kodiak e di leader di opinione nel campo della specializzazione retinica. L'agenda prevede discussioni sulla scienza della durata, formulazioni avanzate, panoramica del programma clinico e delle opportunità offerte da Kodiak.
I relatori includono David Brown, MD, Professore Clinico di Oftalmologia presso la Baylor College of Medicine, e Charles Wykoff, MD, PhD, Professore Clinico di Oftalmologia presso la Weill Cornell Medical College. L'evento presenterà anche in anteprima la Piattaforma ABCD di Kodiak e si concluderà con un riepilogo e una sessione di domande e risposte con il pubblico.
Una trasmissione in diretta, il replay e le diapositive delle presentazioni saranno disponibili sul sito web di Kodiak per Investitori e Media. Questo evento offre un'opportunità agli investitori per ottenere informazioni sugli sforzi di ricerca e sviluppo di Kodiak nel campo dell'oftalmologia.
Kodiak Sciences (Nasdaq: KOD) está celebrando hoy su Día de Inversores y I+D en Nueva York de 10:30 a 12:30 ET. El evento se podrá acceder virtualmente y contará con presentaciones del equipo directivo de Kodiak y líderes de opinión en el campo de la especialización retiniana. La agenda incluye discusiones sobre la ciencia de la durabilidad, formulaciones mejoradas, una visión general del programa clínico y las oportunidades que presenta Kodiak.
Los oradores incluyen a David Brown, MD, Profesor Clínico de Oftalmología en la Baylor College of Medicine, y Charles Wykoff, MD, PhD, Profesor Clínico de Oftalmología en la Weill Cornell Medical College. El evento también presentará en primicia la Plataforma ABCD de Kodiak y concluirá con un resumen y una sesión de preguntas y respuestas con la audiencia.
Una transmisión en vivo, repetición y diapositivas de presentación estarán disponibles en el sitio web de Kodiak para Inversores y Medios. Este evento ofrece una oportunidad para que los inversores obtengan información sobre los esfuerzos de investigación y desarrollo de Kodiak en el campo de la oftalmología.
코디악 사이언스 (Nasdaq: KOD)는 오늘 뉴욕에서 오전 10:30부터 12:30까지 투자자 R&D 데이를 개최합니다. 이 이벤트는 가상으로 접근 가능하며, 코디악의 리더십 팀과 망막 전문의 의견 리더의 발표가 포함됩니다. agenda에는 내구성 과학, 향상된 제형, 임상 프로그램 개요 및 코디악 기회에 대한 논의가 포함됩니다.
연사로는 David Brown, MD, 베일러 의과대학 임상 안과 교수와 Charles Wykoff, MD, PhD, Weill Cornell Medical College 임상 안과 교수가 있습니다. 이 이벤트는 또한 코디악의 ABCD 플랫폼을 미리 소개하고 요약 및 청중 질문과 답변 세션으로 마무리될 것입니다.
라이브 웹캐스트, 재생 및 발표 슬라이드는 코디악의 투자자 및 미디어 웹사이트에서 이용할 수 있습니다. 이 이벤트는 투자자들이 안과 분야에서 코디악의 연구 및 개발 노력에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
Kodiak Sciences (Nasdaq: KOD) organise aujourd'hui sa Journée Investisseurs R&D à New York de 10h30 à 12h30 ET. L'événement sera accessible virtuellement et comportera des présentations de l'équipe dirigeante de Kodiak ainsi que d'experts en ophtalmologie rétinienne. L'agenda comprend des discussions sur la science de la durabilité, les formulations améliorées, un aperçu du programme clinique et les opportunités offertes par Kodiak.
Les intervenants comprennent David Brown, MD, Professeur Clinique d'Ophthalmologie à la Baylor College of Medicine, et Charles Wykoff, MD, PhD, Professeur Clinique d'Ophthalmologie au Weill Cornell Medical College. L'événement présentera également en avant-première la Plateforme ABCD de Kodiak et se conclura par un résumé et une session de questions-réponses avec le public.
Une diffusion en direct, un replay et des diaporamas seront disponibles sur le site web Investisseurs & Médias de Kodiak. Cet événement offre l'occasion aux investisseurs d'obtenir des informations sur les efforts de recherche et développement de Kodiak dans le domaine de l'ophtalmologie.
Kodiak Sciences (Nasdaq: KOD) veranstaltet heute von 10:30 bis 12:30 Uhr ET in New York seinen Investoren-Forschungstag. Die Veranstaltung ist virtuell zugänglich und wird Präsentationen des Führungsteams von Kodiak sowie führender Meinungsführer im Bereich der Netzhautspezialisten umfassen. Die Agenda umfasst Diskussionen über die wissenschaftlichen Grundlagen der Dauerhaftigkeit, verbesserte Formulierungen, einen Überblick über das klinische Programm und die Möglichkeiten von Kodiak.
Zu den Rednern gehören David Brown, MD, klinischer Professor für Ophthalmologie am Baylor College of Medicine, und Charles Wykoff, MD, PhD, klinischer Professor für Ophthalmologie am Weill Cornell Medical College. Die Veranstaltung wird auch die ABCD-Plattform von Kodiak vorstellen und mit einer Zusammenfassung sowie einer Fragen-und-Antworten-Runde mit dem Publikum abschließen.
Ein Live-Stream, Wiederholungen und Präsentationsfolien sind auf der Investor & Medien-Website von Kodiak verfügbar. Diese Veranstaltung bietet Investoren die Möglichkeit, Einblicke in die Forschungs- und Entwicklungsarbeit von Kodiak im Bereich der Ophthalmologie zu erhalten.
- None.
- None.
A link to the live webcast, replay and presentation slides of the event will be available on the "Events and Presentations" section of Kodiak's Investors & Media website at http://ir.kodiak.com/. A replay of the webcast will be available for a limited time following the event.
The event will feature speakers from members of the Kodiak leadership team and the following leading retina specialist key opinion leaders (KOLs):
- David Brown, MD, Clinical Professor of Ophthalmology, Baylor College of Medicine; Director of Research, Retina Consultants of
Texas ,Houston, TX ; Chair, Medical Leadership Board, Retina Consultants of America - Charles Wykoff, MD, PhD, Clinical Professor of Ophthalmology Weill Cornell Medical College, Houston Methodist Hospital; Clinical Professor of Ophthalmology, Blanton Eye Institute; Director of Research, Retina Consultants of
Texas ; Deputy Chair of Ophthalmology, Blanton Eye Institute
Kodiak's Investor R&D Day Agenda
- Why Kodiak
Victor Perlroth, M.D. - Science of Durability
David Brown, M.D. - Science of the Enhanced Formulation
David Brown, M.D. - Roundtable Discussion
- Clinical Program Overview
Charles Wykoff, M.D., Ph.D. - The Kodiak Opportunity
Victor Perlroth, M.D. - Roundtable Discussion
- ABCD Platform Preview
Dolly Chang, M.D., Ph.D. - Summary and Takeaways
Victor Perlroth, M.D. - Audience Q&A
About Kodiak Sciences Inc.
Kodiak Sciences (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing, and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally.
For more information, please visit www.kodiak.com.
Kodiak®, Kodiak Sciences®, ABC™, ABC Platform™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.
View original content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-host-investor-rd-day-today-at-1030am-eastern-time-302254951.html
SOURCE Kodiak Sciences Inc.
FAQ
When and where is Kodiak Sciences (KOD) hosting its Investor R&D Day?
Who are the key speakers at Kodiak Sciences' (KOD) Investor R&D Day?
What topics will be covered during Kodiak Sciences' (KOD) Investor R&D Day?
How can investors access Kodiak Sciences' (KOD) Investor R&D Day?
